DOCSLIB.ORG

(RACK1) Protein

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
(RACK1) Protein ANTICANCER RESEARCH 26: 4539-4548 (2006) The Prion-like Protein Doppel (Dpl) Interacts with the Human Receptor for Activated C-Kinase 1 (RACK1) Protein ALBERTO AZZALIN, IGOR DEL VECCHIO, LUCA FERRETTI and SERGIO COMINCINI Dipartimento di Genetica e Microbiologia, Università di Pavia, via Ferrata 1, 27100 Pavia, Italy Abstract. Background: Doppel (Dpl) is a homologue of the expressed in the testis, especially in Sertoli cells and in prion protein (PrPC). In contrast to PrPC, Dpl is dispensable for spermatozoa, and its involvement in male fertility has been prion disease, but appears to have an essential function in male recently proposed (4, 5). NMR studies of Dpl have revealed a spermatogenesis. Recently, Dpl has been found to be aberrantly high structural similarity with the prion protein (PrPC) (6, 7), expressed in astrocytic and leukaemic tumor specimens, showing which supported the possibility that the two proteins share a peculiar cytosolic cellular localization. The aim of this study similar functions in vivo. Despite a multitude of studies, the was to clarify some of the putative Dpl interacting proteins. cellular functions of Dpl and PrPC are still unknown. However, Materials and Methods: A yeast two hybrid system was employed current data suggested that Dpl, unlike PrPC, is probably not and the results were verified by co-immunoprecipitation using required for the pathogenesis of prion diseases (8, 9) and is not transfected cells. Results: Several potential Dpl-binding converted into a PrPSc-like isoform (10, 11). Importantly, Dpl candidates were identified and, among them, the receptor for can cause Purkinje cell death and ataxia when over-expressed activated C-kinase (RACK1) protein was further investigated. in Prnp-ablated mice (12). These mice are rescued from RACK1 deletion mutants showed that some of its WD neuronal degeneration by the re-introduction of a Prnp containing domains were directly involved in the binding with transgene, arguing that the absence of PrPC is necessary for Dpl. Our data showed that Dpl interacts with RACK1 by means Dpl to induce cell death (13) and that PrPC and Dpl may of its structured globular carboxyl-terminal region. Conclusion: compete for a common ligand (14). This possible PrPC-Dpl This new Dpl interacting partner might suggest functional interplay has attracted research towards the identification of hypotheses about the role of this protein in an astrocytoma common interacting proteins in order to highlight their cellular context where Dpl was found ectopically expressed. functions. In particular, several efforts have been made in order to investigate the function of PrPC, identifying many Doppel (Dpl) is an N-glycosylated, glycosylphosphati- protein interactants, although several appear to be located in dylinositol (GPI) membrane-anchored prion-like protein cellular compartments that are not compatible to sustain encoded by the prion gene (PRND) gene, which has been interactions (15). Pivotal studies of Dpl interactants started found downstream of the PRNP in several species, including with the evidence of common biochemical and topological human, mouse, cattle, sheep and goat (1-3). Dpl is highly features between Dpl and PrPC and moved towards the identification of common protein partners. To date, only one PrPC interacting protein, namely the 37 kDa/67 kDa laminin receptor (LRP) has been reported to interact also with Dpl Abbreviations: AD, activation domain; BD, binding domain; (16); besides, our group has recently reported the absence of DMEM, Dulbecco’s modified Eagle’s medium; ONPG, 2- Dpl interaction with two cytoplasmic PrPC interacting proteins, nitrophenyl ‚-D-galactopyranoside; PBS, phosphate-buffered namely GFAP and Grb2 (17), while others have reported the saline; SDS-PAGE, sodium dodecyl sulfate polyacrylamide gel C electrophoresis; X-Gal, 5-bromo-4-chloro-3-indolyl-beta-D- failure of Dpl-Dpl and Dpl-PrP interactions (18). Due to the galactopyranoside; WD, tryptophan-aspartic acid; GPI, glucosyl- incompleteness of these data, it would be useful to perform a phosphatidylinositol; LRP, laminin receptor, GFAP, glial fibrillary wider screening of Dpl interacting proteins. Thus, in this acidic protein; Grb2, growth factor receptor-bound protein2. contribution a yeast two hybrid assay is described that suggests the binding of Dpl to the receptor for activated Correspondence to: Dr. Sergio Comincini, Dipartimento di C-kinase 1 (RACK1) protein. Our results may provide new Genetica e Microbiologia, via Ferrata 1, Università di Pavia, 27100 insights into the identification of Dpl cellular functions, Pavia, Italy. Tel: +39 0382 985539, Fax: +39 0382 528496, e-mail: [email protected] particularly in some types of cancer, such as the astrocytomas, where we recently described an aberrant accumulation of Dpl Key Words: Doppel, RACK1, protein interaction. in the cellular cytoplasm (19). 0250-7005/2006 $2.00+.40 4539 ANTICANCER RESEARCH 26: 4539-4548 (2006) Table I. The table shows all the oligonucleotides designed and employed in this work. The bases flanking the gene-specific sequences are in bold; restriction sites (underlined) and endonucleases are indicated. PCR thermal profile was: 94ÆC for 3 min, 31 cycles of 94ÆC for 20 sec, 62ÆC for 30 sec, 72ÆC for 1 min; final extension at 72ÆC for 10 min. Name Sequence (5'-3') Restriction enzyme Yeast Two Hybrid Assay: YDpl26E-U CCG GAA TTC ACG AGG GGC ATC AAG CAC A EcoRI YDpl152B-L CGG GAT CCT TAG CCC CTC TCC AAC CAA AAC BamHI RACK-U TTC CAT ATG ATG ACT GAG CAG ATG ACC CTT NdeI RACK-L CGA GCT CGG CGT GTG CCA ATG GTC AC SacI Rwd4-U TTC CAT ATG GTG TGC AAA TAC ACT GTC CAG NdeI Rwd5-U TTC CAT ATG AAC TGC AAG CTG AAG ACC AAC NdeI Rwd6-U TTC CAT ATG AAC GAA GGC AAA CAC CTT TAC AC NdeI Rwd7-U TTC CAT ATG CTG AAG CAA GAA GTT ATC AGT AC NdeI Rwd5-L CGA GCT CGG AGA TCC CAT AAC ATG GCC T SacI Rwd4-L CGA GCT CGA GCC AGG TTC CAT ACC TTG A SacI Rwd3-L CGA GCT CGA CCC AGG GTA TTC CAT AGC T SacI Rwd2-L CGA GCT CGT GTG AGA TCC CAG AGG CG SacI Rwd1-L CGA GCT CGA TCC CTG GTC AGT TTC CAC A SacI Co-immunoprecipitation: Dpl26-U GGA ATT CCC ACG AGG GGC ATC AAG CAC A EcoRI Dpl152-L ATT TGC GGC CGC TTA GCC CCT CTC CAA CCA AAA C NotI Dpl53-U CCG CTC GAG CGG AGA ACC GCC CGG GAG XhoI Dpl53-L ATT TGC GGC CGC CTC AGC CAC CTG GGC C NotI RACK1-U GGG GTA CCA TGA CTG AGC AGA TGA CCC TT KpnI RACK1-L ATT TGC GGC CGC CTA GCG TGT GCC AAT GGT C NotI Materials and Methods streaked on -Leucine, -Tryptophan, -Histidine, -Adenine quadruple dropout (QDO) medium (Clontech). Single colonies Yeast two hybrid assay. The "BD Matchmakerì Library were subjected to PCR amplification, using the Matchmaker AD Construction & Screening Kit" (Clontech, Palo Alto, CA, USA) was LD-Insert Screening flanking primers, to analyze the sizes of the employed for the yeast two hybrid assay. The bait plasmid inserts contained into the prey plasmids. Transformants were containing the PRND coding region, encoding the 26-152 amino assayed for lacZ reporter transcription by a ‚-galactosidase filter acids fragment, was amplified from human genomic DNA using assay and the positive clones were subjected to a liquid 2- YDpl26E-U and YDpl152B-L primers (Table I). PCR fragments nitrophenyl ‚-D-galactopyranoside (ONPG) assay, following the were sub-cloned into the pGBKT7 plasmid, thus, generating the "Yeast Protocol Handbook" (Clontech). Finally, clones were pDpl(26-152)-bait vector. inoculated overnight at 30ÆC on TDO liquid medium: the culture Prey plasmids were derived from a cDNA library, pellets were treated with 50 U of lyticase (Sigma-Aldrich, St. retrotranscribed from 2 Ìg of total RNA, isolated from a pool of Louis, MO, USA) for 1 h at 30ÆC and the prey plasmids were 12 glioblastoma multiforme resections (19). Four hundred ng extracted with the GeneEluteì Plasmid Miniprep kit (Sigma- cDNA were amplified and co-transformed with 3 Ìg of SmaI- Aldrich). Sequencing of the DNA inserts was performed with linearized pGADT7-Rec AD Cloning Vector (Clontech) into the BigDye® Terminator Cycle Sequencing kit v 1.1 (Applied S. cerevisiae yeast strain AH109 (MATa, trp1-901, leu2-3, 112, ura3- Biosystems, Foster City, CA, USA), subjected to automated ® 52, his3-200,gal4¢, gal80¢, LYS2 :: GAL1UAS-GAL1TATA-HIS3, sequencer analysis (ABI PRISM 310 Genetic Analyzer, Applied GAL2UAS -GAL2TATA-ADE2, URA3 :: MEL1UAS-MEL1TATA-lacZ, Biosystems). The sequences were finally analyzed for nucleotide MEL1), following the manufacturer’s instructions. similarities with Genbank database entries using the BLAST After an in vivo recombination-mediated cloning, algorithm (http://www.ncbi.nlm.nih.gov/BLAST/). transformants were plated on a -Leucine single dropout (SD) Different portions of the RACK1 sequence were amplified from medium (Clontech), recovered and transformed again into the the cDNA library with the primers containing NdeI and SacI AH109 strain with 5 Ìg of the pDpl(26-152)-bait plasmid. restriction sites, shown in Table I; the primer pairs used for each Transformants were plated on -Leucine, -Tryptophan, -Histidine construct are shown in Figure 1. PCR products were sequenced, triple dropout (TDO) medium (Clontech). Colonies appeared sub-cloned into pGADT7 plasmids and subjected to ONPG liquid after 5-6 days of incubation at 30ÆC and were subsequently assays, in the presence of the pDpl(26-152)-bait plasmid. 4540 Azzalin et al: Dpl Interacts with RACK1 Figure 1. ONPG liquid assays of protein extracts from cells containing the bait construct, BD/Dpl(26-152), and the RACK1 deletion mutants (AD/RACK1¢). The figure shows, from the left, the employed primer pairs used to obtain mutants, the name of the AD/RACK1¢ fusion proteins produced, the schematic representation of the deleted proteins with the indication of RACK1 residues (between square brackets) and the ‚-galactosidase activity.
Load more

Recommended publications
  • The Significance of the Evolutionary Relationship of Prion Proteins and ZIP Transporters in Health and Disease
    The Significance of the Evolutionary Relationship of Prion Proteins and ZIP Transporters in Health and Disease by Sepehr Ehsani A thesis submitted in conformity with the requirements for the degree of Doctor of Philosophy Department of Laboratory Medicine and Pathobiology University of Toronto © Copyright by Sepehr Ehsani 2012 The Significance of the Evolutionary Relationship of Prion Proteins and ZIP Transporters in Health and Disease Sepehr Ehsani Doctor of Philosophy Department of Laboratory Medicine and Pathobiology University of Toronto 2012 Abstract The cellular prion protein (PrPC) is unique amongst mammalian proteins in that it not only has the capacity to aggregate (in the form of scrapie PrP; PrPSc) and cause neuronal degeneration, but can also act as an independent vector for the transmission of disease from one individual to another of the same or, in some instances, other species. Since the discovery of PrPC nearly thirty years ago, two salient questions have remained largely unanswered, namely, (i) what is the normal function of the cellular protein in the central nervous system, and (ii) what is/are the factor(s) involved in the misfolding of PrPC into PrPSc? To shed light on aspects of these questions, we undertook a discovery-based interactome investigation of PrPC in mouse neuroblastoma cells (Chapter 2), and among the candidate interactors, identified two members of the ZIP family of zinc transporters (ZIP6 and ZIP10) as possessing a PrP-like domain. Detailed analyses revealed that the LIV-1 subfamily of ZIP transporters (to which ZIPs 6 and 10 belong) are in fact the evolutionary ancestors of prions (Chapter 3).
    [Show full text]
  • Pdgfb and P53 in Brain Tumorigenesis
    From the Department of Oncology-Pathology Karolinska Institutet, Stockholm, Sweden PDGFB AND P53 IN BRAIN TUMORIGENESIS Sanna-Maria Hede Stockholm 2010 All previously published papers were reproduced with permission from the publisher. Published by Karolinska Institutet. Printed by Larserics Digital Print AB. © Sanna-Maria Hede, 2010 ISBN 978-91-7457-054-0 ABSTRACT Glioblastoma is the most common, and malignant form of brain tumor. It is characterized by a rapid growth and diffuse spread to surrounding brain tissue. The cell of origin is still not known, but experimental data suggest an origin from a glial precursor or neural stem cell. Analysis of human glioma tissue has revealed many genetic aberrations, among which mutations and loss of TP53 together with amplification and over-expression of PDGFRA are common. Many of the pathways that are found mutated in gliomas, are normally important in regulating stem cell functions. We have investigated the role of p53 in adult neural stem cells, and found that the p53 protein is expressed in the SVZ in mice. Comparison of neurosphere cultures derived from wt and Trp53-/- mice showed that neural stem cells lacking p53 have an increased self-renewal capacity, proliferate faster and display reduced apoptosis. Gene expression profiling revealed differential expression of many genes, the most prominent being Cdkn1a (p21) which was down-regulated in Trp53-/- neural stem cells. Mice lacking p53 do not develop gliomas, but the combination of TP53 mutation/deletion together with other genetic aberrations is common in human gliomas of all grades. We generated a transgenic mouse model mimicking human glioblastoma, by over-expressing PDGFB under the GFAP promoter in Trp53-/- mice.
    [Show full text]
  • AP-1- Dependent Pathway Receptor, Focal
    Peptidoglycan Enhances IL-6 Production in Human Synovial Fibroblasts via TLR2 Receptor, Focal Adhesion Kinase, Akt, and AP-1- Dependent Pathway This information is current as of September 25, 2021. Yung-Cheng Chiu, Ching-Yuang Lin, Chao-Ping Chen, Kui-Chou Huang, Kwok-Man Tong, Chung-Yuh Tzeng, Tu-Sheng Lee, Horng-Chaung Hsu and Chih-Hsin Tang J Immunol 2009; 183:2785-2792; Prepublished online 27 July 2009; Downloaded from doi: 10.4049/jimmunol.0802826 http://www.jimmunol.org/content/183/4/2785 http://www.jimmunol.org/ References This article cites 38 articles, 20 of which you can access for free at: http://www.jimmunol.org/content/183/4/2785.full#ref-list-1 Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists by guest on September 25, 2021 • Fast Publication! 4 weeks from acceptance to publication *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2009 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology Peptidoglycan Enhances IL-6 Production in Human Synovial Fibroblasts via TLR2 Receptor, Focal Adhesion Kinase, Akt, and AP-1- Dependent Pathway1 Yung-Cheng Chiu,*§¶ Ching-Yuang Lin,* Chao-Ping Chen,§ Kui-Chou Huang,§ Kwok-Man Tong,§ Chung-Yuh Tzeng,§ Tu-Sheng Lee,§ Horng-Chaung Hsu,2* and Chih-Hsin Tang2†‡ Peptidoglycan (PGN), the major component of the cell wall of Gram-positive bacteria, activates the innate immune system of the host and induces the release of cytokines and chemokines.
    [Show full text]
  • RANK Interaction and Signaling − RANKL Structural and Functional
    Structural and Functional Insights of RANKL −RANK Interaction and Signaling Changzhen Liu, Thomas S. Walter, Peng Huang, Shiqian Zhang, Xuekai Zhu, Ying Wu, Lucy R. Wedderburn, Peifu This information is current as Tang, Raymond J. Owens, David I. Stuart, Jingshan Ren and of October 1, 2021. Bin Gao J Immunol published online 14 May 2010 http://www.jimmunol.org/content/early/2010/05/14/jimmun ol.0904033 Downloaded from Why The JI? Submit online. http://www.jimmunol.org/ • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication *average Subscription Information about subscribing to The Journal of Immunology is online at: by guest on October 1, 2021 http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. Published May 14, 2010, doi:10.4049/jimmunol.0904033 The Journal of Immunology Structural and Functional Insights of RANKL–RANK Interaction and Signaling Changzhen Liu,*,†,1 Thomas S. Walter,‡,1 Peng Huang,x Shiqian Zhang,{ Xuekai Zhu,*,† Ying Wu,*,† Lucy R. Wedderburn,‖ Peifu Tang,x Raymond J. Owens,‡ David I. Stuart,‡ Jingshan Ren,‡ and Bin Gao*,†,‖ Bone remodeling involves bone resorption by osteoclasts and synthesis by osteoblasts and is tightly regulated by the receptor activator of the NF-kB ligand (RANKL)/receptor activator of the NF-kB (RANK)/osteoprotegerin molecular triad.
    [Show full text]
  • Endothelial LRP1 Transports Amyloid-Β1–42 Across the Blood- Brain Barrier
    Endothelial LRP1 transports amyloid-β1–42 across the blood- brain barrier Steffen E. Storck, … , Thomas A. Bayer, Claus U. Pietrzik J Clin Invest. 2016;126(1):123-136. https://doi.org/10.1172/JCI81108. Research Article Neuroscience According to the neurovascular hypothesis, impairment of low-density lipoprotein receptor–related protein-1 (LRP1) in brain capillaries of the blood-brain barrier (BBB) contributes to neurotoxic amyloid-β (Aβ) brain accumulation and drives Alzheimer’s disease (AD) pathology. However, due to conflicting reports on the involvement of LRP1 in Aβ transport and the expression of LRP1 in brain endothelium, the role of LRP1 at the BBB is uncertain. As global Lrp1 deletion in mice is lethal, appropriate models to study the function of LRP1 are lacking. Moreover, the relevance of systemic Aβ clearance to AD pathology remains unclear, as no BBB-specific knockout models have been available. Here, we developed transgenic mouse strains that allow for tamoxifen-inducible deletion of Lrp1 specifically within brain endothelial cells (Slco1c1- CreERT2 Lrp1fl/fl mice) and used these mice to accurately evaluate LRP1-mediated Aβ BBB clearance in vivo. Selective 125 deletion of Lrp1 in the brain endothelium of C57BL/6 mice strongly reduced brain efflux of injected [ I] Aβ1–42. Additionally, in the 5xFAD mouse model of AD, brain endothelial–specific Lrp1 deletion reduced plasma Aβ levels and elevated soluble brain Aβ, leading to aggravated spatial learning and memory deficits, thus emphasizing the importance of systemic Aβ elimination via the BBB. Together, our results suggest that receptor-mediated Aβ BBB clearance may be a potential target for treatment and prevention of Aβ brain accumulation in AD.
    [Show full text]
  • Guidelines for PRNP Genetic Testing Document Number: 2019PS03 Publication Date: 12 2019 Replaces: New Review Date: 12 2023
    HUMAN GENETICS SOCIETY OF AUSTRALASIA ARBN. 076 130 937 (Incorporated Under the Associations Incorporation Act) The liability of members is limited PO Box 6012, Alexandria, NSW 2015 ABN No. 17 076 130 937 Telephone: 02 9669 6602 Fax: 02 9669 6607 Email: [email protected] Position Statement Title: Guidelines for PRNP genetic testing Document Number: 2019PS03 Publication Date: 12 2019 Replaces: New Review Date: 12 2023 Guidelines for PRNP genetic testing I. PREFACE The following guidelines are recommended procedures and should be viewed as a framework of recommended procedures, not regulations. The recommendations concern the use of genetic testing for the detection of mutations in the prion protein gene (PRNP) and are intended for use by healthcare providers assisting families affected by or suspected to be affected by prion disease and to assist at-risk individuals and those who chose to be tested. These guidelines have been developed by a committee consisting of representatives of clinical genetic services, genetic testing laboratories, the CJD Support Group Network (CJDSGN) and the Australian National Creutzfeldt-Jakob Disease Registry (ANCJDR). Feedback and information from the New Zealand CJD Register, Human Genetics Society of Australasia and Genetic Services is incorporated. A lay version of the guidelines can be requested directly from the CJDSGN and ANCJDR or downloaded from links below, to ensure that patient families are able to make independent informed decisions. www.florey.edu.au/science-research/scientific-services-facilities/australian-national-cjd-registry/cjd- diagnostic-tests - PRNP www.cjdsupport.org.au/site/wp-content/uploads/2019/08/PRNP-Guidelines-final-.pdf 1 II.
    [Show full text]
  • Identification of Potential Key Genes and Pathway Linked with Sporadic Creutzfeldt-Jakob Disease Based on Integrated Bioinformatics Analyses
    medRxiv preprint doi: https://doi.org/10.1101/2020.12.21.20248688; this version posted December 24, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission. Identification of potential key genes and pathway linked with sporadic Creutzfeldt-Jakob disease based on integrated bioinformatics analyses Basavaraj Vastrad1, Chanabasayya Vastrad*2 , Iranna Kotturshetti 1. Department of Biochemistry, Basaveshwar College of Pharmacy, Gadag, Karnataka 582103, India. 2. Biostatistics and Bioinformatics, Chanabasava Nilaya, Bharthinagar, Dharwad 580001, Karanataka, India. 3. Department of Ayurveda, Rajiv Gandhi Education Society`s Ayurvedic Medical College, Ron, Karnataka 562209, India. * Chanabasayya Vastrad [email protected] Ph: +919480073398 Chanabasava Nilaya, Bharthinagar, Dharwad 580001 , Karanataka, India NOTE: This preprint reports new research that has not been certified by peer review and should not be used to guide clinical practice. medRxiv preprint doi: https://doi.org/10.1101/2020.12.21.20248688; this version posted December 24, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission. Abstract Sporadic Creutzfeldt-Jakob disease (sCJD) is neurodegenerative disease also called prion disease linked with poor prognosis. The aim of the current study was to illuminate the underlying molecular mechanisms of sCJD. The mRNA microarray dataset GSE124571 was downloaded from the Gene Expression Omnibus database. Differentially expressed genes (DEGs) were screened.
    [Show full text]
  • Multiomics of Azacitidine-Treated AML Cells Reveals Variable And
    Multiomics of azacitidine-treated AML cells reveals variable and convergent targets that remodel the cell-surface proteome Kevin K. Leunga, Aaron Nguyenb, Tao Shic, Lin Tangc, Xiaochun Nid, Laure Escoubetc, Kyle J. MacBethb, Jorge DiMartinob, and James A. Wellsa,1 aDepartment of Pharmaceutical Chemistry, University of California, San Francisco, CA 94143; bEpigenetics Thematic Center of Excellence, Celgene Corporation, San Francisco, CA 94158; cDepartment of Informatics and Predictive Sciences, Celgene Corporation, San Diego, CA 92121; and dDepartment of Informatics and Predictive Sciences, Celgene Corporation, Cambridge, MA 02140 Contributed by James A. Wells, November 19, 2018 (sent for review August 23, 2018; reviewed by Rebekah Gundry, Neil L. Kelleher, and Bernd Wollscheid) Myelodysplastic syndromes (MDS) and acute myeloid leukemia of DNA methyltransferases, leading to loss of methylation in (AML) are diseases of abnormal hematopoietic differentiation newly synthesized DNA (10, 11). It was recently shown that AZA with aberrant epigenetic alterations. Azacitidine (AZA) is a DNA treatment of cervical (12, 13) and colorectal (14) cancer cells methyltransferase inhibitor widely used to treat MDS and AML, can induce interferon responses through reactivation of endoge- yet the impact of AZA on the cell-surface proteome has not been nous retroviruses. This phenomenon, termed viral mimicry, is defined. To identify potential therapeutic targets for use in com- thought to induce antitumor effects by activating and engaging bination with AZA in AML patients, we investigated the effects the immune system. of AZA treatment on four AML cell lines representing different Although AZA treatment has demonstrated clinical benefit in stages of differentiation. The effect of AZA treatment on these AML patients, additional therapeutic options are needed (8, 9).
    [Show full text]
  • Gene Expression and Signal Transduction
    Chapter14 Gene Expression and Signal Transduction PLANT BIOLOGISTS MAY BE FORGIVEN for taking abiding satisfac- tion in the fact that Mendel’s classic studies on the role of heritable fac- tors in development were carried out on a flowering plant: the garden pea. The heritable factors that Mendel discovered, which control such characteristics as flower color, flower position, pod shape, stem length, seed color, and seed shape, came to be called genes. Genes are the DNA sequences that encode the RNA molecules directly involved in making the enzymes and structural proteins of the cell. Genes are arranged lin- early on chromosomes, which form linkage groups—that is, genes that are inherited together. The total amount of DNA or genetic information contained in a cell, nucleus, or organelle is termed its genome. Since Mendel’s pioneering discoveries in his garden, the principle has become firmly established that the growth, development, and environ- mental responses of even the simplest microorganism are determined by the programmed expression of its genes. Among multicellular organ- isms, turning genes on (gene expression) or off alters a cell’s comple- ment of enzymes and structural proteins, allowing cells to differentiate. In the chapters that follow, we will discuss various aspects of plant development in relation to the regulation of gene expression. Various internal signals are required for coordinating the expression of genes during development and for enabling the plant to respond to environmental signals. Such internal (as well as external) signaling agents typically bring about their effects by means of sequences of bio- chemical reactions, called signal transduction pathways, that greatly amplify the original signal and ultimately result in the activation or repression of genes.
    [Show full text]
  • Biochem II Signaling Intro and Enz Receptors
    Signal Transduction What is signal transduction? Binding of ligands to a macromolecule (receptor) “The secret life is molecular recognition; the ability of one molecule to “recognize” another through weak bonding interactions.” Linus Pauling Pleasure or Pain – it is the receptor ligand recognition So why do cells need to communicate? -Coordination of movement bacterial movement towards a chemical gradient green algae - colonies swimming through the water - Coordination of metabolism - insulin glucagon effects on metabolism -Coordination of growth - wound healing, skin. blood and gut cells Hormones are chemical signals. 1) Every different hormone binds to a specific receptor and in binding a significant alteration in receptor conformation results in a biochemical response inside the cell 2) This can be thought of as an allosteric modification with two distinct conformations; bound and free. Log Dose Response • Log dose response (Fractional Bound) • Measures potency/efficacy of hormone, agonist or antagonist • If measuring response, potency (efficacy) is shown differently Scatchard Plot Derived like kinetics R + L ó RL Used to measure receptor binding affinity KD (KL – 50% occupancy) in presence or absence of inhibitor/antagonist (B = Receptor bound to ligand) 3) The binding of the hormone leads to a transduction of the hormone signal into a biochemical response. 4) Hormone receptors are proteins and are typically classified as a cell surface receptor or an intracellular receptor. Each have different roles and very different means of regulating biochemical / cellular function. Intracellular Hormone Receptors The steroid/thyroid hormone receptor superfamily (e.g. glucocorticoid, vitamin D, retinoic acid and thyroid hormone receptors) • Protein receptors that reside in the cytoplasm and bind the lipophilic steroid/thyroid hormones.
    [Show full text]
  • Unaltered Intravenous Prion Disease Pathogenesis in the Temporary Absence of Marginal Zone B Cells Barry M
    www.nature.com/scientificreports OPEN Unaltered intravenous prion disease pathogenesis in the temporary absence of marginal zone B cells Barry M. Bradford & Neil A. Mabbott * Prion diseases are a unique, infectious, neurodegenerative disorders that can afect animals and humans. Data from mouse transmissions show that efcient infection of the host after intravenous (IV) prion exposure is dependent upon the early accumulation and amplifcation of the prions on stromal follicular dendritic cells (FDC) in the B cell follicles. How infectious prions are initially conveyed from the blood-stream to the FDC in the spleen is uncertain. Addressing this issue is important as susceptibility to peripheral prion infections can be reduced by treatments that prevent the early accumulation of prions upon FDC. The marginal zone (MZ) in the spleen contains specialized subsets of B cells and macrophages that are positioned to continuously monitor the blood-stream and remove pathogens, toxins and apoptotic cells. The continual shuttling of MZ B cells between the MZ and the B-cell follicle enables them to efciently capture and deliver blood-borne antigens and antigen-containing immune complexes to splenic FDC. We tested the hypothesis that MZ B cells also play a role in the initial shuttling of prions from the blood-stream to FDC. MZ B cells were temporarily depleted from the MZ by antibody-mediated blocking of integrin function. We show that depletion of MZ B cells around the time of IV prion exposure did not afect the early accumulation of blood-borne prions upon splenic FDC or reduce susceptibility to IV prion infection. In conclusion, our data suggest that the initial delivery of blood-borne prions to FDC in the spleen occurs independently of MZ B cells.
    [Show full text]
  • Prion Disease and the Innate Immune System
    Viruses 2012, 4, 3389-3419; doi:10.3390/v4123389 OPEN ACCESS viruses ISSN 1999-4915 www.mdpi.com/journal/viruses Review Prion Disease and the Innate Immune System Barry M. Bradford and Neil A. Mabbott * The Roslin Institute and Royal (Dick) School of Veterinary Studies, The University of Edinburgh, Easter Bush Campus, Midlothian, EH25 9RG, UK; E-Mail: [email protected] * Author to whom correspondence should be addressed; E-Mail: [email protected]; Tel.: +44-131-651-9100; Fax: +44-131-651-9105. Received: 6 October 2012; in revised form: 14 November 2012 / Accepted: 22 November 2012 / Published: 28 November 2012 Abstract: Prion diseases or transmissible spongiform encephalopathies are a unique category of infectious protein-misfolding neurodegenerative disorders. Hypothesized to be caused by misfolding of the cellular prion protein these disorders possess an infectious quality that thrives in immune-competent hosts. While much has been discovered about the routing and critical components involved in the peripheral pathogenesis of these agents there are still many aspects to be discovered. Research into this area has been extensive as it represents a major target for therapeutic intervention within this group of diseases. The main focus of pathological damage in these diseases occurs within the central nervous system. Cells of the innate immune system have been proven to be critical players in the initial pathogenesis of prion disease, and may have a role in the pathological progression of disease. Understanding how prions interact with the host innate immune system may provide us with natural pathways and mechanisms to combat these diseases prior to their neuroinvasive stage.
    [Show full text]